KKR & Co. Investing Cash Flow increased by 155.4% to $2.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 174.6%, from -$3.15B to $2.35B. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 19.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.17B | -$4.47B | -$2.59B | -$2.00B | -$5.09B | -$3.59B | -$2.97B | -$3.82B | -$1.08B | -$6.20B | -$5.48B | -$5.12B | -$2.25B | -$3.15B | -$1.89B | -$7.01B | -$4.24B | $2.35B |
| QoQ Change | — | -105.7% | +42.1% | +22.8% | -155.0% | +29.5% | +17.4% | -28.7% | +71.8% | -475.7% | +11.7% | +6.5% | +56.0% | -39.7% | +39.9% | -270.7% | +39.5% | +155.4% |
| YoY Change | — | — | — | — | -134.5% | +19.7% | -14.6% | -91.1% | +70.0% | -62.3% | — | -375.4% | — | +49.2% | +65.5% | -36.9% | -88.1% | +174.6% |